Geanie Pai

Geanie Pai is an experienced scientist currently working at Sorrento Therapeutics, Inc. since January 2018, where responsibilities have included engineering antibody-like molecules, optimizing purification methods for bispecific antibodies, and developing T cell-recruiting bispecific antibodies. Prior roles included Associate Scientist at Sorrento Therapeutics, where a universal CAR-T platform was initiated and antibody libraries were constructed targeting COVID-19, and Senior Research Associate, focused on CAR-T and CAR-NK engineering. Previous experience includes Research Associate positions at ProSci Inc., The University of Texas at Austin, and the Institute of Molecular Biology, Academia Sinica in Taiwan, where various antibody production, genetic screenings, and functional assays were conducted. Geanie Pai holds a Bachelor of Science in Atmospheric Science from National Taiwan University and a Master of Science in Biochemistry from National Yang Ming University.